Literature DB >> 28159868

Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine.

Javeed Jattan1, Cayla Rodia1, Diana Li1, Adama Diakhate1, Hongli Dong1, Amy Bataille1, Noah F Shroyer2, Alison B Kohan3.   

Abstract

Since its initial report in 2009, the intestinal enteroid culture system has been a powerful tool used to study stem cell biology and development in the gastrointestinal tract. However, a major question is whether enteroids retain intestinal function and physiology. There have been significant contributions describing ion transport physiology of human intestinal organoid cultures, as well as physiology of gastric organoids, but critical studies on dietary fat absorption and chylomicron synthesis in primary intestinal enteroids have not been undertaken. Here we report that primary murine enteroid cultures recapitulate in vivo intestinal lipoprotein synthesis and secretion, and reflect key aspects of the physiology of intact intestine in regard to dietary fat absorption. We also show that enteroids can be used to elucidate intestinal mechanisms behind CVD risk factors, including tissue-specific apolipoprotein functions. Using enteroids, we show that intestinal apoC-III overexpression results in the secretion of smaller, less dense chylomicron particles along with reduced triacylglycerol secretion from the intestine. This model significantly expands our ability to test how specific genes or genetic polymorphisms function in dietary fat absorption and the precise intestinal mechanisms that are critical in the etiology of metabolic disease.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  apolipoprotein C-III; chylomicrons; dietary fat absorption; intestinal lipid transport; organoids; stem cells; triglyceride

Mesh:

Substances:

Year:  2017        PMID: 28159868      PMCID: PMC5408603          DOI: 10.1194/jlr.M071340

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  49 in total

1.  Rare variant APOC3 R19X is associated with cardio-protective profiles in a diverse population-based survey as part of the Epidemiologic Architecture for Genes Linked to Environment Study.

Authors:  Dana C Crawford; Logan Dumitrescu; Robert Goodloe; Kristin Brown-Gentry; Jonathan Boston; Bob McClellan; Cara Sutcliffe; Rachel Wiseman; Paxton Baker; Margaret A Pericak-Vance; William K Scott; Melissa Allen; Ping Mayo; Nathalie Schnetz-Boutaud; Holli H Dilks; Jonathan L Haines; Toni I Pollin
Journal:  Circ Cardiovasc Genet       Date:  2014-11-01

2.  Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.

Authors:  Arman Qamar; Sumeet A Khetarpal; Amit V Khera; Atif Qasim; Daniel J Rader; Muredach P Reilly
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-11       Impact factor: 8.311

3.  Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function.

Authors:  Alison B Kohan; Fei Wang; Xiaoming Li; Suzanne Bradshaw; Qing Yang; Jody L Caldwell; Tera M Bullock; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-29       Impact factor: 4.052

Review 4.  The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.

Authors:  Chao-Qiang Lai; Laurence D Parnell; Jose M Ordovas
Journal:  Curr Opin Lipidol       Date:  2005-04       Impact factor: 4.776

5.  Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.

Authors:  Altan Onat; Gülay Hergenç; Vedat Sansoy; Manfred Fobker; Köksal Ceyhan; Sadik Toprak; Gerd Assmann
Journal:  Atherosclerosis       Date:  2003-05       Impact factor: 5.162

6.  Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.

Authors:  Meenakshi Sundaram; Shumei Zhong; Maroun Bou Khalil; Philip H Links; Yang Zhao; Jahangir Iqbal; M Mahmood Hussain; Robin J Parks; Yuwei Wang; Zemin Yao
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

7.  Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells.

Authors:  Tea Fevr; Sylvie Robine; Daniel Louvard; Joerg Huelsken
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

8.  The chylomicron: relationship to atherosclerosis.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  Int J Vasc Med       Date:  2011-10-05

9.  Chylomicrons produced by Caco-2 cells contained ApoB-48 with diameter of 80-200 nm.

Authors:  Andromeda M Nauli; Yuxi Sun; Judy D Whittimore; Seif Atyia; Guha Krishnaswamy; Surya M Nauli
Journal:  Physiol Rep       Date:  2014-06-06

10.  Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease.

Authors:  Majken K Jensen; Eric B Rimm; Jeremy D Furtado; Frank M Sacks
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

View more
  9 in total

1.  Intestinal basolateral lipid substrate transport is linked to chylomicron secretion and is regulated by apoC-III.

Authors:  Diana Li; Cayla N Rodia; Zania K Johnson; Minkyung Bae; Angelika Muter; Amy E Heussinger; Nicholas Tambini; Austin M Longo; Hongli Dong; Ji-Young Lee; Alison B Kohan
Journal:  J Lipid Res       Date:  2019-05-31       Impact factor: 5.922

2.  The atypical antipsychotic quetiapine induces hyperlipidemia by activating intestinal PXR signaling.

Authors:  Zhaojie Meng; Taesik Gwag; Yipeng Sui; Se-Hyung Park; Xiangping Zhou; Changcheng Zhou
Journal:  JCI Insight       Date:  2019-02-07

Review 3.  Controlling the polarity of human gastrointestinal organoids to investigate epithelial biology and infectious diseases.

Authors:  Julia Y Co; Mar Margalef-Català; Denise M Monack; Manuel R Amieva
Journal:  Nat Protoc       Date:  2021-10-18       Impact factor: 13.491

4.  Bile acid composition regulates the manganese transporter Slc30a10 in intestine.

Authors:  Tiara R Ahmad; Sei Higuchi; Enrico Bertaggia; Allison Hung; Niroshan Shanmugarajah; Nicole C Guilz; Jennifer R Gamarra; Rebecca A Haeusler
Journal:  J Biol Chem       Date:  2020-07-20       Impact factor: 5.157

5.  Functional genomics analysis of human colon organoids identifies key transcription factors.

Authors:  Shiyi Yin; Greeshma Ray; Jenny L Kerschner; Shuyu Hao; Aura Perez; Mitchell L Drumm; James A Browne; Shih-Hsing Leir; Michelle Longworth; Ann Harris
Journal:  Physiol Genomics       Date:  2020-05-11       Impact factor: 3.107

Review 6.  Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology.

Authors:  Manuel Noben; Wiebe Vanhove; Kaline Arnauts; Anabela Santo Ramalho; Gert Van Assche; Séverine Vermeire; Catherine Verfaillie; Marc Ferrante
Journal:  United European Gastroenterol J       Date:  2017-07-21       Impact factor: 4.623

7.  ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance.

Authors:  Bastian Ramms; Sohan Patel; Chelsea Nora; Ariane R Pessentheiner; Max W Chang; Courtney R Green; Gregory J Golden; Patrick Secrest; Ronald M Krauss; Christian M Metallo; Christopher Benner; Veronica J Alexander; Joseph L Witztum; Sotirios Tsimikas; Jeffrey D Esko; Philip L S M Gordts
Journal:  J Lipid Res       Date:  2019-05-14       Impact factor: 5.922

Review 8.  Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.

Authors:  Jun-Hwan Yoo; Mark Donowitz
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.374

Review 9.  The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.

Authors:  Jan Borén; Chris J Packard; Marja-Riitta Taskinen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-28       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.